Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: migraines


Drug’s ability to lower frequency of migraines by 50 percent sounds pretty good–until you read the fine print


Emerging migraine treatments: NPR story deftly weighs the good, the bad and the unknowns


Guardian story on new migraine drug never establishes why it’s ‘an important step forward’


Reuters Health carefully hedges results of study on mild shocks for migraines


Heavy on anecdote and light on evidence: NBC News’s story on experimental migraine drug